Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 800

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 800
---
496 |
| Prepaid expenses                                |     |              |       — |     |   | 154,520 |
| Total prepaid expenses and other current assets |     | $            | 925,382 |     | $ | 297,998 |

Note 4

Property and Equipment, net:

The following table shows the property and equipment consisted of the following as of December 31, 2023 and 2022:

| Cost                              |     | December 31, 
 2023         |         |   |     | 2022 |         |   |
|:----------------------------------|:----|:-------------|--------:|:--|:----|:-----|--------:|:--|
| Furniture and fixtures            |     | $            |  13,341 |   |     | $    |  13,341 |   |
| Software                          |     |              |  26,219 |   |     |      |  26,219 |   |
| Total cost                        |     |              |  39,560 |   |     |      |  39,560 |   |
| Accumulated depreciation          |     |              | (32,866 | ) |     |      | (21,458 | ) |
| Total property and equipment, net |     | $            |   6,694 |   |     | $    |  18,102 |   |

Deprecation and related amortization expense was $ and $ for the years ended December 31, 2023 and 2022.

Note 5 Related party short-term Loans On November 15, 2023, the Company entered into a series of short term loan agreements (the “Short Term Loan Agreements”) with certain existing shareholders of the Company, including Ronald Hafner, the Company’s Chairman of the Board of Directors, Felix Grisard, Jürgen Bauer and Maria Nayvalt, providing for unsecured loans to the Company in the aggregate amount of CHF 875,000.00(approximately $ 1,000,000). The loans bear interest at a rate

Annex F-129 NLS PHARMACEUTICS LTD.
NOTES TO THE FINANCIAL STATEMENTS

of 10% per annum and mature on the earlier of June 30, 2024, or a liquidity event with a strategic partner. In addition, the Company and Mr. Hafner agreed to extend the maturity